Secukinumab (AIN457) in the treatment of ankylosing spondylitis
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.2016.1167183
Reference86 articles.
1. The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?
2. Spondyloarthritis
3. Prevalence of axial spondylarthritis in the United States: Estimates from a cross-sectional survey
4. Enhanced reactivity to pain in patients with rheumatoid arthritis
5. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease;Cellular and Molecular Life Sciences;2024-08-17
2. Case report: Inflammatory bowel disease triggered by secukinumab in a female case of axial spondyloarthritis accompanied with symptomatic epilepsy;International Journal of Rheumatic Diseases;2024-05
3. Treatment of non-systemic juvenile idiopathic arthritis;Nature Reviews Rheumatology;2024-02-06
4. Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium”;Journal of Clinical Medicine;2022-12-19
5. Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis;Rheumatology International;2022-09-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3